Glenmark Pharmaceuticals declares Rs 2.50 interim dividend, rejigs board committees

Disclaimer This is an AI-assisted live blog with updates sourced from multiple news outlets and agencies Disclaimer

Trade

• Watchlist
• Portfolio
• Message
• Set Alert

 

 

Choose Stock Exchange: BSE LIVE NSE LIVE

26 Aug, 2025 12:21

Volume

Todays L/H

More

×

Glenmark Pharmaceuticals Ltd said its board of directors, at a meeting held on September 26, 2025, approved the payment of an interim dividend of Rs 2.50 per equity share of face value Re 1 for FY26. The dividend amounts to Rs 705.50 million in total. The record date has been set as October 3, 2025, and the dividend will be paid within 30 days of declaration.

The board also approved the reconstitution of several committees with effect from October 1, 2025:

• Stakeholders Relationship Committee: Chaired by Ms. Sona Saira Ramasastry, with Mrs. Cherylann Pinto and Ms. Patricia Andrews as members.
• Risk Management Committee: Chaired by Mr. Dipankar Bhattacharjee, with Mr. Glenn Saldanha, Ms. Patricia Andrews, and Mr. Anurag Mantri as members.
• ESG (Environmental, Social and Governance) Committee: Chaired by Mr. Glenn Saldanha, with Ms. Sona Saira Ramasastry, Mr. Pradeep Kumar Sinha, and Ms. Patricia Andrews as members.

The company’s market capitalisation currently stands at about Rs 558.5 billion, and it trades at a price-to-earnings multiple of 74.07. Glenmark Pharma stock has a dividend yield of 0.13 percent.